Accuracy and Periodontal Outcomes of Three Interproximal Enamel Reduction Techniques During Clear Aligner Therapy

2.1. Aim This study aims to compare, in patients undergoing clear aligner therapy, the accuracy of interproximal enamel reduction (IPR) and the short term periodontal effects among three techniques: manual hand strips, motor driven oscillating strips, and abrasive discs.

2.2 Objectives

1. To Quantify and compare the accuracy of interproximal enamel reduction among manual hand strips, motor driven oscillating strips, and abrasive discs during clear aligner therapy.
2. To Evaluate and compare the short term periodontal effects of IPR among manual hand strips, motor driven oscillating strips, and abrasive discs
3. Hypothesis and/ or Research Question: There is no difference between manual hand strips, motor driven oscillating strips, and abrasive discs in the accuracy of interproximal enamel reduction and in the short term changes in plaque index and bleeding on probing.
4. Materials and Methods: 4.1. Study Design This study will be a single-blinded randomized controlled clinical trial with three parallel arms and equal allocation of 1:1:1 conducted at the orthodontic clinics of Riyadh Elm University, Riyadh, Saudi Arabia. The trial will be registered at ClinicalTrials.gov and approval will be obtained from the Saudi Food and Drug Authority with ethical approval from Riyadh Elm University Institutional Review Board (IRB). 4.2. Sample size Sample size calculation was performed using GPower (version 3.1.9.6). Based on data reported by Hariharan et al. (2022), a large effect size (Cohen's f = 0.40) was assumed for differences in the accuracy of interproximal reduction between three techniques. With a significance level of 0.05 and a power of 80%, a total sample size of 66 patients was required. Allowing for a 10% dropout rate, 75 patients (25 per group) were planned. 4.3. Study Participants and Experiment:
5. Participants: Adult patients receiving Lite, Moderate or Comprehensive Invisalign® treatment packages (Align Technology, Inc., San Jose, CA, USA) at the orthodontic clinics of Riyadh Elm University, Riyadh, Saudi Arabia, will be screened at the pre treatment visit or at the first scheduled IPR appointment. Eligible patients who provide written informed consent will be enrolled in this study. Eligibility Criteria Inclusion criteria Exclusion criteria Age 18 years or older with full permanent dentition orthodontic treatment plan including extraction Undergoing clear aligner therapy with Invisalign® with a ClinCheck™ treatment plan that includes interproximal enamel reduction Proximal restorations or caries on any tooth surface targeted for interproximal enamel reduction. Periodontally healthy patient Current smoking, diabetes mellitus, or other systemic diseases known to affect periodontal status Exclusion criteria orthodontic treatment plan including extraction Proximal restorations or caries on any tooth surface targeted for interproximal enamel reduction. Current smoking, diabetes mellitus, or other systemic diseases known to affect periodontal status 4.4. Randomization and allocation concealment: Group assignment will use simple randomization in a 1:1:1 ratio generated via a secure web-based random sequence tool. An independent coordinator will prepare a master Excel list linking unique serial numbers (e.g., 001, 002, …) to the three trial arms according to that sequence. Each number will be printed on an identical, opaque ticket. At enrolment, a trained dental assistant will present an opaque draw bowl containing the prepared tickets; the participant will draw one number. The dental assistant will record the patient ID and drawn number in the allocation log and contact the independent coordinator to obtain the corresponding assignment. Used tickets will be retained and not returned to the bowl. 4.5. Intervention: At the IPR visit, an intraoral scan will be acquired using the iTero Element 5D (Align Technology, Inc., San Jose, CA, USA) dental plaque will be assessed using the Plaque Index of Silness and Löe (1964) on teeth scheduled to receive IPR only. Baseline periodontal assessment will be performed only on the teeth scheduled to receive IPR, including Plaque Index (Silness \& Löe, 1964), and Gingival Bleeding Index (Ainamo \& Bay, 1975). IPR will then be performed at the contacts as prescribed in the ClinCheck treatment plan by the same trained and calibrated operator according to the allocated technique. Interproximal clearance will be verified using metal interproximal gauges. A second intraoral scan will be acquired immediately after IPR during the same visit (T1). At 6 weeks after IPR, participants will be recalled and periodontal reassessment will be performed on the same IPR teeth only, using: Plaque Index (Silness \& Löe, 1964), and Gingival Bleeding Index (Ainamo \& Bay, 1975). No polishing and no topical fluoride will be used in any study group. Group 1 Manual abrasive strips will be used, specifically 6 mm Separating Abrasive Strips (coarse) (Ortho Organizers, Inc.). Group 2 Motor driven oscillating strips will be used, specifically the OK Strips KIT with a JAINTEK EVA Ahandpiece operated at less than 15,000 rpm. Group 3 Oscillating segmented discs will be used, specifically Komet oscillating segmented OS discs (OS1Mm). 4.6. Outcomes and measurements Standard Tessellation Language (STL) files will be exported from the iTero platform and imported into OrthoCAD digital software version 5.9.0.36 (3Shape, Copenhagen, Denmark), which will be used to measure the widest mesiodistal diameter of each incisor, canine, and premolar scheduled to receive IPR at baseline before IPR (T0) and immediately after IPR (T1); the amount of IPR performed will be calculated as the difference in the summed mesiodistal widths of the IPR teeth between T0 and T1 and will be compared with the planned IPR values extracted from the initial ClinCheck treatment plan. Periodontal parameters will be assessed on IPR teeth only and compared between baseline and the 6-week follow-up: bleeding on probing will be assessed at six sites per tooth using gentle probing force of approximately 25 g and scored as 0 for absence of bleeding and 1 for presence of bleeding within 10-15 seconds, and plaque will be assessed using the Plaque Index of Silness and Löe (1964) on four surfaces per tooth with scores summed and divided by four to obtain the tooth-level plaque index To assess intra examiner reliability of the OrthoCAD mesiodistal width measurements, a random subsample of 20 participants will be re measured by the same operator after a 2 week interval under identical conditions.
6. Statistical analysis Statistical analysis will be performed using SPSS software (Version 26.0; IBM Corp, Armonk, NY). Descriptive statistics, including means and standard deviations for normally distributed data, or medians and interquartile ranges for non-parametric data, will be calculated for all variables. Intra-examiner reliability for mesiodistal width measurements will be assessed using the Intraclass Correlation Coefficient (ICC) with 95% confidence intervals based on the remeasurement of 20 randomly selected participants. The Shapiro-Wilk test will be used to assess the normality of the data. For the primary outcome (IPR accuracy), if a normal distribution is confirmed, a One-Way Analysis of Variance (ANOVA) will be used to compare the three groups, followed by Tukey's HSD post-hoc test for pairwise comparisons. If normality is violated, the Kruskal-Wallis test with Bonferroni adjustment will be employed. For periodontal measurements (Plaque Index and Gingival Bleeding Index), changes between baseline (T0) and 6-week follow-up (T1) within each group will be analyzed using the Wilcoxon signed-rank test. Comparisons of these changes among the three intervention groups will be conducted using the Kruskal-Wallis test. The level of significance for all tests will be set at p<0.05.
7. Ethical considerations:

Ethical approval will be obtained from Riyadh Elm University Institutional Review Board (IRB) and approval will be obtained from the Saudi Food and Drug Authority as applicable. The trial will be registered on ClinicalTrials.gov before recruitment. Written informed consent will be obtained from all participants. Participants may withdraw at any time without affecting their treatment.